39 research outputs found
Contribution of the golgi Complex—Endoplasmic reticulum system during spermiogenesis in three species of phytophagous bugs (Hemiptera : Pentatomidae)
Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis
<p>Abstract</p> <p>Background</p> <p>Farnesol is a sesquiterpene alcohol produced by many organisms, and also found in several essential oils. Its role as a quorum sensing molecule and as a virulence factor of <it>Candida albicans </it>has been well described. Studies revealed that farnesol affect the growth of a number of bacteria and fungi, pointing to a potential role as an antimicrobial agent.</p> <p>Methods</p> <p>Growth assays of <it>Paracoccidioides brasiliensis </it>cells incubated in the presence of different concentrations of farnesol were performed by measuring the optical density of the cultures. The viability of fungal cells was determined by MTT assay and by counting the colony forming units, after each farnesol treatment. The effects of farnesol on <it>P. brasiliensis </it>dimorphism were also evaluated by optical microscopy. The ultrastructural morphology of farnesol-treated <it>P. brasiliensis </it>yeast cells was evaluated by transmission and scanning electron microscopy.</p> <p>Results</p> <p>In this study, the effects of farnesol on <it>Paracoccidioides brasiliensis </it>growth and dimorphism were described. Concentrations of this isoprenoid ranging from 25 to 300 μM strongly inhibited <it>P. brasiliensis </it>growth. We have estimated that the MIC of farnesol for <it>P. brasiliensis </it>is 25 μM, while the MLC is around 30 μM. When employing levels which don't compromise cell viability (5 to 15 μM), it was shown that farnesol also affected the morphogenesis of this fungus. We observed about 60% of inhibition in hyphal development following <it>P. brasiliensis </it>yeast cells treatment with 15 μM of farnesol for 48 h. At these farnesol concentrations we also observed a significant hyphal shortening. Electron microscopy experiments showed that, despite of a remaining intact cell wall, <it>P. brasiliensis </it>cells treated with farnesol concentrations above 25 μM exhibited a fully cytoplasmic degeneration.</p> <p>Conclusion</p> <p>Our data indicate that farnesol acts as a potent antimicrobial agent against <it>P. brasiliensis</it>. The fungicide activity of farnesol against this pathogen is probably associated to cytoplasmic degeneration. In concentrations that do not affect fungal viability, farnesol retards the germ-tube formation of <it>P. brasiliensis</it>, suggesting that the morphogenesis of this fungal is controlled by environmental conditions.</p
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
<p>Abstract</p> <p>Background</p> <p>Rhodium (II) citrate (Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4</sub>) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, its lower toxicity when compared to carboxylate analogues of rhodium (II) indicates Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4 </sub>as a promising agent for chemotherapy. Nevertheless, few studies have been performed to explore this potential. Superparamagnetic particles of iron oxide (SPIOs) represent an attractive platform as carriers in drug delivery systems (DDS) because they can present greater specificity to tumor cells than normal cells. Thus, the association between Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4 </sub>and SPIOs can represent a strategy to enhance the former's therapeutic action. In this work, we report the cytotoxicity of free rhodium (II) citrate (Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4</sub>) and rhodium (II) citrate-loaded maghemite nanoparticles or magnetoliposomes, used as drug delivery systems, on both normal and carcinoma breast cell cultures.</p> <p>Results</p> <p>Treatment with free Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4 </sub>induced cytotoxicity that was dependent on dose, time, and cell line. The IC<sub>50 </sub>values showed that this effect was more intense on breast normal cells (MCF-10A) than on breast carcinoma cells (MCF-7 and 4T1). However, the treatment with 50 μM Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4</sub>-loaded maghemite nanoparticles (Magh-Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4</sub>) and Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4</sub>-loaded magnetoliposomes (Lip-Magh-Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4</sub>) induced a higher cytotoxicity on MCF-7 and 4T1 than on MCF-10A (p < 0.05). These treatments enhanced cytotoxicity up to 4.6 times. These cytotoxic effects, induced by free Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4</sub>, were evidenced by morphological alterations such as nuclear fragmentation, membrane blebbing and phosphatidylserine exposure, reduction of actin filaments, mitochondrial condensation and an increase in number of vacuoles, suggesting that Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4 </sub>induces cell death by apoptosis.</p> <p>Conclusions</p> <p>The treatment with rhodium (II) citrate-loaded maghemite nanoparticles and magnetoliposomes induced more specific cytotoxicity on breast carcinoma cells than on breast normal cells, which is the opposite of the results observed with free Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4 </sub>treatment. Thus, magnetic nanoparticles represent an attractive platform as carriers in Rh<sub>2</sub>(H<sub>2</sub>cit)<sub>4 </sub>delivery systems, since they can act preferentially in tumor cells. Therefore, these nanopaticulate systems may be explored as a potential tool for chemotherapy drug development.</p
Magnetic resonance investigation of magnetic-labeled baker's yeast cells
In this study, the interaction of DMSA-coated magnetite nanoparticles (5 and 10 nm core-size) with Saccharomyces cerevisae was investigated using magnetic resonance (MR) and transmission electron microscopy (TEM). The TEM micrographs revealed magnetite nanoparticles attached externally to the cell wall. The MR data support the strong interaction among the nanoparticles supported by the cells. A remarkable shift in the resonance field was used as signature of particle attachment to the cell wall
A betabaculovirus encoding a gp64 homolog
Abstract\ud
\ud
Background\ud
A betabaculovirus (DisaGV) was isolated from Diatraea saccharalis (Lepidoptera: Crambidae), one of the most important insect pests of the sugarcane and other monocot cultures in Brazil.\ud
\ud
\ud
Results\ud
The complete genome sequence of DisaGV was determined using the 454-pyrosequencing method. The genome was 98,392 bp long, which makes it the smallest lepidopteran-infecting baculovirus sequenced to date. It had a G + C content of 29.7 % encoding 125 putative open reading frames (ORF). All the 37 baculovirus core genes and a set of 19 betabaculovirus-specific genes were found. A group of 13 putative genes was not found in any other baculovirus genome sequenced so far. A phylogenetic analysis indicated that DisaGV is a member of Betabaculovirus genus and that it is a sister group to a cluster formed by ChocGV, ErelGV, PiraGV isolates, ClanGV, CaLGV, CpGV, CrleGV, AdorGV, PhopGV and EpapGV. Surprisingly, we found in the DisaGV genome a G protein-coupled receptor related to lepidopteran and other insect virus genes and a gp64 homolog, which is likely a product of horizontal gene transfer from Group 1 alphabaculoviruses.\ud
\ud
\ud
Conclusion\ud
DisaGV represents a distinct lineage of the genus Betabaculovirus. It is closely related to the CpGV-related group and presents the smallest genome in size so far. Remarkably, we found a homolog of gp64, which was reported solely in group 1 alphabaculovirus genomes so far.BTP received a scholarship from CAPES through the Graduate Program in\ud
Biotechnology from the University of São Paulo and Butantan Institute. This project was partially funded by CNPq grant 481741/2008-9. We thank Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Apoio à Pesquisa do Distrito Federal (FAPDF)